Fresh approaches to early testing for dementia are increasingly common, but the resulting technology has tended to fall short in terms of results. London-based Cognetivity Neurosciences Ltd. has been developing a compelling solution, the ICA (Integrated Cognitive Assessment) test using natural images that are presented quickly to participants who are asked to accurately indicate whether they have seen a pre-specified image category. The test can be performed on an iPAD, potentially in any setting. The viewed images are processed in the visual cortex, a brain region associated with the earliest signs of neurodegeneration in conditions such as Alzheimer's disease (AD), and are translated to movement in the motor cortex, allowing evaluations to be made based on comparisons with an accurate dataset of clinically-diagnosed subjects. It is a technology that the company believes has applications in and beyond the clinical setting.
The involvement of Cognetivity, a Cambridge spin-out, in the technology began when one of its founders, Dr Seyed-Mahdi Khaligh-Razavi, a...




